This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

Many reproductive cancers, such as ovarian and endometrial cancers, develop silently without noticeable early symptoms.

The European Commission (EC) has approved GSK's Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...